Zobrazeno 1 - 5
of 5
pro vyhledávání: '"My Björklund"'
Publikováno v:
PLoS ONE, Vol 9, Iss 9, p e107109 (2014)
Epithelial ovarian carcinoma (EOC), the major cause of gynaecological cancer death, is a heterogeneous disease classified into five subtypes. Each subtype has distinct clinical characteristics and is associated with different genetic risk factors and
Externí odkaz:
https://doaj.org/article/9d960ee1d5564711951def69ba2bc963
Autor:
Anna Palau, Anne Neddermeyer, Philippe Ruminy, Lucia Cavelier, Henrik Grönberg, Andreas Lennartsson, Vinciane Marchand, Sylvain Mareschal, Anna Eriksson, Christer Nilsson, Marie Engvall, Sofia Bengtzen, Johan Lindberg, Sören Lehmann, My Björklund, Fabrice Jardin, Monika Jansson, Mattias Rantalainen
Publikováno v:
Blood Adv
Although copy number alterations (CNAs) and translocations constitute the backbone of the diagnosis and prognostication of acute myeloid leukemia (AML), techniques used for their assessment in routine diagnostics have not been reconsidered for decade
Autor:
Sören Lehmann, Johan Lindberg, Albin Österroos, Mattias Rantalainen, Sylvain Mareschal, Anna Eriksson, Christer Nilsson, Henrik Grönberg, My Björklund
Publikováno v:
Blood Cancer Journal
Blood Cancer Journal, Vol 10, Iss 6, Pp 1-10 (2020)
Blood Cancer Journal, Vol 10, Iss 6, Pp 1-10 (2020)
Relevant molecular tools for treatment stratification of patients ≥65 years with acute myeloid leukemia (AML) are lacking. We combined clinical data with targeted DNA- and full RNA-sequencing of 182 intensively and palliatively treated patients to
Autor:
Jakob Haglöf, Mikael K.R. Engskog, Maria C. Shoshan, Curt Pettersson, Torbjörn Arvidsson, My Björklund
Publikováno v:
Bioanalysis. 7:157-166
Background: Metabolic profiling represents a novel technology for analyzing tumor cells. Epithelial ovarian carcinoma has a low survival rate due to the development of aggressive and chemotherapy-resistant cells. A tailored and reliable protocol is p
Publikováno v:
PLoS ONE, Vol 9, Iss 9, p e107109 (2014)
PLoS ONE
PLoS ONE
Epithelial ovarian carcinoma (EOC), the major cause of gynaecological cancer death, is a heterogeneous disease classified into five subtypes. Each subtype has distinct clinical characteristics and is associated with different genetic risk factors and